Fortis Memorial Research Institute, Gurugram unveils South Asia’s First Gamma Knife Esprit
(No Ratings Yet)
Loading...
Heralding a new era in the non-surgical high precision treatment of brain tumours, Fortis Memorial Research Institute, Gurugram, has launched South Asia’s ‘First Gamma Knife Esprit’. The Gamma Knife employs computer-guided precision to target brain tumours without actual cutting, making it an optimal choice for treating both malignant and benign tumours, including multiple brain metastases, meningiomas, acoustic tumours, and pituitary adenomas.
Its precision is crucial for tumours in sensitive or hard-to-reach brain areas with sparing healthy brain tissues and allows patients to return to daily activities almost immediately. Further, radiation therapy for multiple brain metastasis requires almost 30 sessions, in contrast, Gamma Knife radiosurgery consolidates the entire treatment into a single session with same day discharge, making the treatment swift and efficient. Additionally, Gamma Knife can treat multiple metastasis in a single session irrespective of metastatic lesions involved, a benefit not offered by other technologies. This method significantly minimizes radiation exposure to healthy tissues, preserving motor, sensory nerve and neurocognitive function enabling rapid recovery and improved healthy quality of life after treatment.
Fortis Healthcare has introduced Gamma Knife technology, a time-tested, reliable method with extensive clinical validation and high confidence among clinicians and patients across India and worldwide. This integrated and efficient system boasts a guaranteed accuracy of 0.3 mm, delivering doses to healthy brain tissue that are 2–4x lower than other technologies, with 2–21x lower extracranial doses. This highest accuracy and precision in Gamma knife reduces toxicities and side effects to normal brain. Gamma Knife ensures high success rate for controlling brain tumours and other brain conditions with minimal side effects. Gamma Knife radiosurgery boasts an impressive track record with a control rate surpassing 95% over a span of 10 years, providing reassuring long-term relief.
Dr. Sandeep Vaishya, Director Neurosurgery, Fortis Gurgaon, said “The launch of South Asia’s first Gamma Knife Esprit at our facility marks a significant milestone in the field of neurosurgery. This advanced technology brings a level of precision to neurosurgical procedures that was previously unattainable, targeting brain tumours with pinpoint accuracy. The Gamma Knife Esprit minimizes the radiation exposure to healthy tissues which is crucial for reducing potential side effects. This capability allows us to enhance patient safety and comfort significantly, thus optimizing the recovery process. By drastically cutting down recovery times, we are not only improving clinical outcomes but also enhancing the overall patient experience. This is a step forward in our ongoing effort to push the boundaries of what’s possible in medical treatment and patient care.”
Anil Vinayak, Group COO, Fortis Healthcare, elaborated on the broader vision of Fortis as a leader in comprehensive cancer care: “Deploying the first Gamma Knife Esprit in South Asia is a testament to Fortis Healthcare’s commitment in integrating cutting-edge technologies in neurosurgery and holistic cancer care. Our commitment extends beyond just offering advanced treatments; it encompasses providing comprehensive care that enhances the overall patient journey and outcomes. This initiative is another step in reinforcing our position at the forefront of medical innovation and patient-centric care across the region.”
